Evidence map›Paper›PMID 26206890›Full record

ArticleHuman molecular genetics2015

Mutations in the histamine N-methyltransferase gene, HNMT, are associated with nonsyndromic autosomal recessive intellectual disability.

Abolfazl Heidari, Chanakan Tongsook, Reza Najafipour, Luciana Musante, Nasim Vasli, Masoud Garshasbi, Hao Hu, Kirti Mittal, Amy J M McNaughton, Kumudesh Sritharan and 24 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Histamine: A Key Neuromodulator of Memory Consolidation and Retrieval.Current topics in behavioral neurosciences · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. HistamineInternational journal of molecular sciences · 2019
    Review
  14. Article
  15. Mapping of the binding sites of human histamine N-methyltransferase (HNMT) monoclonal antibodies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 17 institutions in 8 countries.

Abolfazl HeidariMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8, Cellular and Molecular Research Center.
Chanakan TongsookInstitute of Biochemistry, Graz University of Technology, Graz 8010, Austria.
Reza NajafipourCellular and Molecular Research Center.
Luciana MusanteMax Planck Institute of Molecular Genetics, Berlin D-14195, Germany.
Nasim VasliMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8.
Masoud GarshasbiMax Planck Institute of Molecular Genetics, Berlin D-14195, Germany, Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14117-13116, Iran.
Hao HuMax Planck Institute of Molecular Genetics, Berlin D-14195, Germany.
Kirti MittalMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8.
Amy J M McNaughtonOngwanada Genomics Lab.
Kumudesh SritharanMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8.
Melissa HudsonOngwanada Genomics Lab.
Henning StehrDepartment of Medicine, Stanford University, Stanford, CA 94305-5101, USA.
Saeid TalebiDepartment of Medical Genetics, Medical University of Tehran, Tehran 14167-53955, Iran.
Mohammad MoradiCellular and Molecular Research Center.
Hossein DarvishDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran 4739, Iran.
Muhammad Arshad RafiqMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8.
Hossein MozhdehipanahDepartment of Neurology, Bou Ali Sina Hospital, Qazvin University of Medical Sciences, Qazvin 34197/59811, Iran.
Ali RashidinejadMaternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran 1419733141, Iran.
Shahram SamieiBlood Transfusion Research Center, Tehran 1449613111, Iran.
Mohsen GhadamiDepartment of Medical Genetics, Tehran University of Medical Sciences, Tehran 1417613151, Iran.
Christian WindpassingerInstitute of Human Genetics, Medical University of Graz, Graz 8010, Austria.
Gabriele Gillessen-KaesbachInstitut für Humangenetik, Universität zu Lübeck, Lübeck 23562, Germany.
Andreas TzschachMax Planck Institute of Molecular Genetics, Berlin D-14195, Germany.
Iltaf AhmedMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8, Atta-ur-Rehman School of Applied Biosciences, National University of Sciences and Technology, H-12, Islamabad, Pakistan.
Anna MikhailovMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8.
D James StavropoulosDepartment of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.
Melissa T CarterDivision of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Soraya KeshavarzCellular and Molecular Research Center.
Muhammad AyubDivision of Developmental Disabilities, Department of Psychiatry, Queen's University, Kingston, ON, Canada K7L7X3.
Hossein NajmabadiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran 19857, Iran, Kariminejad-Najmabadi Pathology and Genetics Center, Tehran 14667, Iran.
Xudong LiuOngwanada Genomics Lab.
Hans Hilger RopersMax Planck Institute of Molecular Genetics, Berlin D-14195, Germany.
Peter MacherouxInstitute of Biochemistry, Graz University of Technology, Graz 8010, Austria.
John B VincentMolecular Neuropsychiatry and Development (MiND) Lab, The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada M5T 1R8, Department of Psychiatry, University of Toronto, Toronto, ON, Canada M5T 1R8 and Institute of Medical Science, University of Toronto, Toronto, ON, Canada M5S 1A8 john.vincent@camh.ca.
Max Planck Institute for Molecular Genetics · DEMental Health Research Institute · AUCellular Research (United States) · USCentre for Addiction and Mental Health · CAGenomics (United Kingdom) · GBGraz University of Technology · ATHospital for Sick Children · CATehran University of Medical Sciences · IRHigh Institute for Education and Research in Transfusion Medicine · IRMedical University of Graz · ATQueen's University · CAShahid Beheshti University of Medical Sciences · IRSina Hospital · IRStanford University · USUniversity of Lübeck · DEUniversity of Social Welfare and Rehabilitation Sciences · IRUniversity of Tehran · IR

Funding

Canadian Institutes of Health Research MOP-102758
6 · The paper itself

Abstract

Histamine (HA) acts as a neurotransmitter in the brain, which participates in the regulation of many biological processes including inflammation, gastric acid secretion and neuromodulation. The enzyme histamine N-methyltransferase (HNMT) inactivates HA by transferring a methyl group from S-adenosyl-l-methionine to HA, and is the only well-known pathway for termination of neurotransmission actions of HA in mammalian central nervous system. We performed autozygosity mapping followed by targeted exome sequencing and identified two homozygous HNMT alterations, p.Gly60Asp and p.Leu208Pro, in patients affected with nonsyndromic autosomal recessive intellectual disability from two unrelated consanguineous families of Turkish and Kurdish ancestry, respectively. We verified the complete absence of a functional HNMT in patients using in vitro toxicology assay. Using mutant and wild-type DNA constructs as well as in silico protein modeling, we confirmed that p.Gly60Asp disrupts the enzymatic activity of the protein, and that p.Leu208Pro results in reduced protein stability, resulting in decreased HA inactivation. Our results highlight the importance of inclusion of HNMT for genetic testing of individuals presenting with intellectual disability.

Indexed as

Genes, RecessiveMutation, MissenseAdolescentAdultAmino Acid SequenceCatalytic DomainChildChild, PreschoolComputer SimulationDNA Mutational AnalysisExomeFemaleHistamine N-MethyltransferaseHumansInfantIntellectual DisabilityHistamine N-Methyltransferase

Identifiers

PMID26206890
PMCPMC4581600
OpenAlexW1830908103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.